Finance

Lists
002462:SHE
Cachet Pharmaceutical Co., Ltd
CN¥11.82
-0.17%
(-0.020) 1D
Oct 20, 3:04:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002462...
Open
CN¥11.85
High
CN¥11.89
Low
CN¥11.68
Mkt. cap
3.45B
Avg. vol.
2.44M
Volume
2.10M
Dividend
0.97%
Quarterly dividend
CN¥0.03
Ex-dividend date
Aug 28, 2026
P/E ratio
37.94
52-wk high
CN¥19.69
52-wk low
CN¥10.57
EPS
CN¥0.31
Shares outstanding
291.71M
No. of employees
2K
Open
CN¥11.85
High
CN¥11.89
Low
CN¥11.68
Mkt. cap
3.45B
Avg. vol.
2.44M
Volume
2.10M
Dividend
0.97%
Quarterly dividend
CN¥0.03
Ex-dividend date
Aug 28, 2026
P/E ratio
37.94
52-wk high
CN¥19.69
52-wk low
CN¥10.57
EPS
CN¥0.31
Shares outstanding
291.71M
No. of employees
2K
News stories
From web sources and news partners
About Cachet Pharmaceutical Co., Ltd
CEO-
Employees1.74K
FoundedApr 22, 1997
Headquarters-
SectorHealth care provider
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
4.76B
5.07B
3.97B
4.31B
Cost of goods sold
4.47B
4.79B
3.75B
4.05B
Cost of revenue
4.47B
4.79B
3.75B
4.05B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
153.20M
105.46M
118.26M
123.74M
Operating expense
230.75M
220.72M
137.42M
158.00M
Total operating expenses
4.70B
5.01B
3.89B
4.20B
Operating income
61.97M
59.36M
85.75M
101.81M
Other non operating income
14.45M
-15.85M
-
-11.38M
EBT including unusual items
61.05M
-14.05M
77.74M
102.88M
EBT excluding unusual items
54.37M
35.44M
79.22M
88.92M
Income tax expense
32.07M
75.73M
26.01M
40.50M
Effective tax rate
52.54%
-539.05%
33.45%
39.37%
Other operating expenses
8.22M
9.18M
4.61M
10.23M
Net income
34.07M
-29.95M
38.08M
48.68M
Net profit margin
0.72%
-0.59%
0.96%
1.13%
Earnings per share
-
-
-
-
Interest and investment income
-
14.99M
5.82M
5.79M
Interest expense
-22.05M
-23.07M
-12.34M
-7.27M
Net interest expenses
-22.05M
-8.08M
-6.52M
-1.48M
Depreciation and amortization charges
-
-
-
-
EBITDA
74.81M
65.21M
91.59M
106.52M
Gain or loss from assets sale
-690.61K
-4.31M
-
550.24K
AI content may include mistakes. Learn more
Google apps